Globitair

Stock market

MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours

Financial PostUnited States of America

MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours

New white paper shows LensAI™ immunogenicity screening running at up to 43% lower cost per sequence on Amazon EC2 Hpc8a instances powered by AMD EPYC processors, making a critical drug-safety check practical at the scale AI-driven discovery now demands AUSTIN, Texas — MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today published a […]

Read the full story at Financial PostOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about United States of America

More on Stock market